Angiodynamics Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Public

  • Employees
  • 632

Employees

  • Stock Symbol
  • ANGO

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $10.76
  • (As of Thursday Closing)

Angiodynamics General Information

Description

AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.

Contact Information

Formerly Known As
E-Z-EM
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 14 Plaza Drive
  • Latham, NY 12110
  • United States
+1 (800)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Corporate Office
  • 14 Plaza Drive
  • Latham, NY 12110
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiodynamics Stock Performance

As of 19-Nov-2026, Angiodynamics’s stock price is $10.76. Its current market cap is $453M with 42.1M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.76 $11.32 $9.39 - $16.29 $453M 42.1M 647K -$0.78

Angiodynamics Financials Summary

As of 31-Aug-2026, Angiodynamics has a trailing 12-month revenue of $325M.

In Thousands,
USD
TTM 31-Aug-2026 FY 2026 31-May-2026 FY 2025 31-May-2025 FY 2024 31-May-2024
EV 612,827 436,531 374,431 174,293
Revenue 325,378 320,174 292,498 303,914
EBITDA (9,872) (13,046) (9,210) (165,540)
Net Income (32,936) (36,742) (33,993) (184,349)
Total Assets 241,933 267,163 280,144 317,671
Total Debt 0 0 0 4,728
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Angiodynamics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angiodynamics‘s full profile, request access.

Request a free trial

Angiodynamics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and impr
Surgical Devices
Latham, NY
632 As of 2026

South Jordan, UT
 

Alameda, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Angiodynamics Competitors (48)

One of Angiodynamics’s 48 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merit Medical Systems Corporation South Jordan, UT
Penumbra Formerly VC-backed Alameda, CA
ShockWave Medical Formerly VC-backed Santa Clara, CA
Inari Medical Formerly VC-backed Irvine, CA
Teleflex Corporation Wayne, PA
You’re viewing 5 of 48 competitors. Get the full list »

Angiodynamics Patents

Angiodynamics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1084316-S1 Ferrule Active 20-Nov-2023
US-20250025189-A1 Aspiration systems and methods for removal of undesired material from a circulatory system Pending 20-Jul-2023
US-20240148956-A1 Filter for mechanical thrombectomy device and method of using the same Pending 07-Nov-2022
US-20230149073-A1 Method and device for probe navigation of an ablation system Pending 15-Nov-2021
US-20230030606-A1 Device and method of use for aspiration system retrievers Pending 20-Jul-2021 A61B17/221
To view Angiodynamics’s complete patent history, request access »

Angiodynamics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiodynamics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angiodynamics‘s full profile, request access.

Request a free trial

Angiodynamics Investments & Acquisitions (15)

Angiodynamics’s most recent deal was a Corporate Asset Purchase with QX Medical (Camaro Support Catheter Asset) for . The deal was made on 27-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
QX Medical (Camaro Support Catheter Asset) 27-Jul-2021 Corporate Asset Purchase Buildings and Property
AngioDynamics (PICC, Midline, and Tip Location Product) 17-Dec-2020 Corporate Asset Purchase Buildings and Property
Eximo 02-Oct-2019 Merger/Acquisition Therapeutic Devices
RadiaDyne 21-Sep-2018 Merger/Acquisition Therapeutic Devices
Surgical Specialties (BioSentry Tract Sealant System) 14-Aug-2018 Corporate Asset Purchase Other Devices and Supplies
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Angiodynamics ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

32.88 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Angiodynamics’s complete esg history, request access »

Angiodynamics Exits (4)

Angiodynamics’s most recent exit was on 17-Dec-2020 from AngioDynamics (PICC, Midline, and Tip Location Product). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
AngioDynamics (PICC, Midline, and Tip Location Product) 17-Dec-2020 Completed
Merz (Distribution rights of Asclera) 10-Mar-2016 Completed
EmboMedics 01-Apr-2015 Completed
AngioCare 01-Jan-2011 Merger/Acquisition Completed
To view Angiodynamics’s complete exits history, request access »

Angiodynamics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Diomed Andover, MA 1997

Angiodynamics FAQs

  • When was Angiodynamics founded?

    Angiodynamics was founded in 1988.

  • Where is Angiodynamics headquartered?

    Angiodynamics is headquartered in Latham, NY.

  • What is the size of Angiodynamics?

    Angiodynamics has 632 total employees.

  • What industry is Angiodynamics in?

    Angiodynamics’s primary industry is Surgical Devices.

  • Is Angiodynamics a private or public company?

    Angiodynamics is a Public company.

  • What is Angiodynamics’s stock symbol?

    The ticker symbol for Angiodynamics is ANGO.

  • What is the current stock price of Angiodynamics?

    As of 19-Nov-2026 the stock price of Angiodynamics is $10.76.

  • What is the current market cap of Angiodynamics?

    The current market capitalization of Angiodynamics is $453M.

  • What is Angiodynamics’s current revenue?

    The trailing twelve month revenue for Angiodynamics is $325M.

  • Who are Angiodynamics’s competitors?

    Merit Medical Systems, Penumbra, ShockWave Medical, Inari Medical, and Teleflex are some of the 48 competitors of Angiodynamics.

  • What is Angiodynamics’s annual earnings per share (EPS)?

    Angiodynamics’s EPS for 12 months was -$0.78.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process